Arbovax, a Raleigh, NC company, is focused on the commercialization of a novel and innovative technology to facilitate the development of vaccines against insect-borne viruses. The initial focus includes Dengue Fever and Yellow Fever. Subsequent targets include Japanese Encephalitis and West Nile.

Bioptigen, a Durham, NC company, has developed advanced technology, through patent and licensing agreements with Duke University, in the field of Optical Coherence Tomography (OCT). OCT enables a non-invasive, real-time two- and three-dimensional imaging of living subjects with resolution up to 100-times finer than 4D ultrasound techniques.

Effectur, Greensboro, NC, is a technology-based solutions provider focused on the IRS resolution industry. Effectur resolves IRS problems by providing relief from enforced collection activities and settling outstanding tax debts for clients through the use of its proprietary software tools.

Merscom is a global publisher of computer and video games that distributes through multiple channels, multiple platforms and multiple revenue models. Merscom's channels include retail distribution in the US and Europe, online sales through major portals worldwide, and games on Microsoft® Xbox Live® Arcade. Merscom publishes games from leading casual game developers on multiple platforms including PC, console and handheld devices. Merscom produces entertaining products for gamers of all ages.

Southeast TechInventures is a technology accelerator for the rapid conversion of university scientific breakthroughs into products, services and new technology companies. STI works with university-based inventors to accelerate the commercialization of technologies and intellectual property in biotechnology (medical devices, bioengineering), display technology, IT, and nanotechnology.